S&P 500   4,591.02 (+0.51%)
DOW   36,223.29 (+0.76%)
QQQ   389.79 (+0.25%)
AAPL   191.28 (+0.70%)
MSFT   374.74 (-1.10%)
META   325.14 (-0.61%)
GOOGL   131.71 (-0.62%)
AMZN   146.92 (+0.57%)
TSLA   237.69 (-1.00%)
NVDA   467.25 (-0.10%)
NIO   7.19 (-1.10%)
BABA   73.82 (-1.42%)
AMD   121.07 (-0.07%)
T   16.70 (+0.78%)
F   10.55 (+2.83%)
MU   75.85 (-0.35%)
CGC   0.62 (+11.46%)
GE   122.98 (+0.97%)
DIS   92.38 (-0.33%)
AMC   6.88 (+3.46%)
PFE   28.90 (-5.15%)
PYPL   59.67 (+3.58%)
XOM   102.73 (+-0.01%)
S&P 500   4,591.02 (+0.51%)
DOW   36,223.29 (+0.76%)
QQQ   389.79 (+0.25%)
AAPL   191.28 (+0.70%)
MSFT   374.74 (-1.10%)
META   325.14 (-0.61%)
GOOGL   131.71 (-0.62%)
AMZN   146.92 (+0.57%)
TSLA   237.69 (-1.00%)
NVDA   467.25 (-0.10%)
NIO   7.19 (-1.10%)
BABA   73.82 (-1.42%)
AMD   121.07 (-0.07%)
T   16.70 (+0.78%)
F   10.55 (+2.83%)
MU   75.85 (-0.35%)
CGC   0.62 (+11.46%)
GE   122.98 (+0.97%)
DIS   92.38 (-0.33%)
AMC   6.88 (+3.46%)
PFE   28.90 (-5.15%)
PYPL   59.67 (+3.58%)
XOM   102.73 (+-0.01%)
S&P 500   4,591.02 (+0.51%)
DOW   36,223.29 (+0.76%)
QQQ   389.79 (+0.25%)
AAPL   191.28 (+0.70%)
MSFT   374.74 (-1.10%)
META   325.14 (-0.61%)
GOOGL   131.71 (-0.62%)
AMZN   146.92 (+0.57%)
TSLA   237.69 (-1.00%)
NVDA   467.25 (-0.10%)
NIO   7.19 (-1.10%)
BABA   73.82 (-1.42%)
AMD   121.07 (-0.07%)
T   16.70 (+0.78%)
F   10.55 (+2.83%)
MU   75.85 (-0.35%)
CGC   0.62 (+11.46%)
GE   122.98 (+0.97%)
DIS   92.38 (-0.33%)
AMC   6.88 (+3.46%)
PFE   28.90 (-5.15%)
PYPL   59.67 (+3.58%)
XOM   102.73 (+-0.01%)
S&P 500   4,591.02 (+0.51%)
DOW   36,223.29 (+0.76%)
QQQ   389.79 (+0.25%)
AAPL   191.28 (+0.70%)
MSFT   374.74 (-1.10%)
META   325.14 (-0.61%)
GOOGL   131.71 (-0.62%)
AMZN   146.92 (+0.57%)
TSLA   237.69 (-1.00%)
NVDA   467.25 (-0.10%)
NIO   7.19 (-1.10%)
BABA   73.82 (-1.42%)
AMD   121.07 (-0.07%)
T   16.70 (+0.78%)
F   10.55 (+2.83%)
MU   75.85 (-0.35%)
CGC   0.62 (+11.46%)
GE   122.98 (+0.97%)
DIS   92.38 (-0.33%)
AMC   6.88 (+3.46%)
PFE   28.90 (-5.15%)
PYPL   59.67 (+3.58%)
XOM   102.73 (+-0.01%)

Definitive Healthcare Stock Price, News & Analysis (NASDAQ:DH)

$8.42
+0.17 (+2.06%)
(As of 02:39 PM ET)
Compare
Today's Range
$8.07
$8.43
50-Day Range
$5.70
$8.38
52-Week Range
$5.53
$14.03
Volume
197,691 shs
Average Volume
782,381 shs
Market Capitalization
$979.50 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$11.94

Definitive Healthcare MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
41.8% Upside
$11.94 Price Target
Short Interest
Bearish
13.79% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.66mentions of Definitive Healthcare in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
28.57%
From $0.07 to $0.09 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.07 out of 5 stars

Medical Sector

539th out of 949 stocks

Prepackaged Software Industry

108th out of 203 stocks


DH stock logo

About Definitive Healthcare Stock (NASDAQ:DH)

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution. The company's platform consists of various functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing firms and commercial real estate companies, financial institutions, and other organizations in the healthcare ecosystem. The company was founded in 2011 and is headquartered in Framingham, Massachusetts.

DH Stock Price History

DH Stock News Headlines

Trading Experts Call It “The Perfect Tesla Trade”
Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.
Trading Experts Call It “The Perfect Tesla Trade”
Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.
Definitive Healthcare (NASDAQ: DH)
Definitive Healthcare acquires Populi
See More Headlines
Receive DH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Definitive Healthcare and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/02/2023
Today
12/01/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
2/22/2024

Industry, Sector and Symbol

Industry
Prepackaged software
Sub-Industry
N/A
Sector
Medical
Fax
N/A
Employees
946
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$11.94
High Stock Price Target
$15.00
Low Stock Price Target
$9.50
Potential Upside/Downside
+41.9%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
8 Analysts

Profitability

Net Income
$-7,220,000.00
Pretax Margin
-124.82%

Debt

Sales & Book Value

Annual Sales
$222.65 million
Cash Flow
$0.73 per share
Book Value
$10.35 per share

Miscellaneous

Free Float
98,565,000
Market Cap
$978.34 million
Optionable
Not Optionable
Beta
0.84
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for December 2023. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Jason Ronald Krantz (Age 49)
    Founder & Executive Chairman
    Comp: $820.92k
  • Mr. Robert W. Musslewhite J.D. (Age 53)
    CEO & Director
    Comp: $709.08k
  • Mr. Jon Maack
    President
  • Mr. Richard Douglas BoothMr. Richard Douglas Booth (Age 54)
    Chief Financial Officer
    Comp: $562.44k
  • Ms. Kate Marie Shamsuddin Jensen (Age 37)
    Chief Product Officer
    Comp: $393.26k
  • Mr. Scott Oberlink
    Chief Technology Officer
  • Mr. Matt Ruderman
    Chief Legal Officer & Secretary
  • Mr. Justin A. Steinman
    Chief Marketing Officer
  • Mr. Craig Hazenfield
    Chief People Officer
  • Mr. Ram Sharma
    Executive Vice President of Life Sciences














DH Stock Analysis - Frequently Asked Questions

Should I buy or sell Definitive Healthcare stock right now?

8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Definitive Healthcare in the last year. There are currently 4 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" DH shares.
View DH analyst ratings
or view top-rated stocks.

What is Definitive Healthcare's stock price target for 2024?

8 brokers have issued 12-month target prices for Definitive Healthcare's stock. Their DH share price targets range from $9.50 to $15.00. On average, they anticipate the company's share price to reach $11.94 in the next twelve months. This suggests a possible upside of 41.8% from the stock's current price.
View analysts price targets for DH
or view top-rated stocks among Wall Street analysts.

How have DH shares performed in 2023?

Definitive Healthcare's stock was trading at $10.99 at the beginning of 2023. Since then, DH stock has decreased by 23.4% and is now trading at $8.42.
View the best growth stocks for 2023 here
.

Are investors shorting Definitive Healthcare?

Definitive Healthcare saw a increase in short interest in November. As of November 15th, there was short interest totaling 6,370,000 shares, an increase of 25.6% from the October 31st total of 5,070,000 shares. Based on an average daily trading volume, of 840,700 shares, the days-to-cover ratio is currently 7.6 days. Currently, 13.8% of the shares of the stock are short sold.
View Definitive Healthcare's Short Interest
.

When is Definitive Healthcare's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 22nd 2024.
View our DH earnings forecast
.

How were Definitive Healthcare's earnings last quarter?

Definitive Healthcare Corp. (NASDAQ:DH) issued its earnings results on Thursday, November, 2nd. The company reported $0.01 earnings per share for the quarter, missing the consensus estimate of $0.02 by $0.01. The company had revenue of $65.33 million for the quarter, compared to the consensus estimate of $63.60 million. Definitive Healthcare had a negative net margin of 73.75% and a positive trailing twelve-month return on equity of 0.50%.

What ETFs hold Definitive Healthcare's stock?
What guidance has Definitive Healthcare issued on next quarter's earnings?

Definitive Healthcare updated its fourth quarter earnings guidance on Thursday, November, 2nd. The company provided EPS guidance of $0.06-0.08 for the period, compared to the consensus estimate of $0.03. The company issued revenue guidance of $65.5-66.5 million, compared to the consensus revenue estimate of $66.90 million.

When did Definitive Healthcare IPO?

(DH) raised $350 million in an initial public offering (IPO) on Wednesday, September 15th 2021. The company issued 15,555,555 shares at a price of $21.00-$24.00 per share.

Who are Definitive Healthcare's major shareholders?

Definitive Healthcare's stock is owned by a variety of institutional and retail investors. Top institutional investors include JPMorgan Chase & Co. (4.36%), Conestoga Capital Advisors LLC (4.35%), Brown Advisory Inc. (3.50%), Riverbridge Partners LLC (2.30%), Fred Alger Management LLC (2.20%) and Clearbridge Investments LLC (1.94%). Insiders that own company stock include David Randall Winn, Jeffrey Charles Haywood, Richard Douglas Booth and Sea Vii Management, Llc.
View institutional ownership trends
.

How do I buy shares of Definitive Healthcare?

Shares of DH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:DH) was last updated on 12/1/2023 by MarketBeat.com Staff

My Account -